 |
Corporate News
21-Mar-25
|
 |
|
|
|
|
|
Lupin allots 24,101 equity shares under ESOP
|
|
|
|
Lupin has allotted 24,101 equity shares under ESOP on 21 March 2025. In view of the above, the issued and paid-up share capital of the Company has increased to Rs 91,31,30,090 consisting of 45,65,65,045 equity shares of Rs 2/- each.
|
|
Previous News |
Lupin gets USFDA nod for Loteprednol Etabonate Ophthalmic Gel
(
Hot Pursuit
-
02-Jul-25
12:53
)
|
|
Lupin carves-out its LupinLife Consumer Healthcare
(
Corporate News
-
01-Jul-25
18:39
)
|
|
Lupin receives USFDA approval for Loteprednol Etabonate Ophthalmic Gel
(
Corporate News
-
01-Jul-25
18:37
)
|
|
Lupin update on transfer of its OTC biz to LUPINLIFE Consumer Healthcare
(
Corporate News
-
30-Jun-25
18:54
)
|
|
Lupin launches Prucalopride tablets in U.S. market
(
Hot Pursuit
-
26-Jun-25
13:12
)
|
|
Lupin launches Prucalopride Tablets in US market
(
Corporate News
-
26-Jun-25
13:05
)
|
|
Lupin receives USFDA approval for generic Prucalopride tablets
(
Hot Pursuit
-
25-Jun-25
13:47
)
|
|
Lupin receives USFDA approval for Prucalopride Tablets
(
Corporate News
-
25-Jun-25
13:29
)
|
|
Lupin allots 20,653 equity shares under ESOP
(
Corporate News
-
24-Jun-25
19:04
)
|
|
Lupin inks licensing deal with Sino Universal pharma for Tiotropium DPI drug in China
(
Hot Pursuit
-
16-Jun-25
11:07
)
|
|
Lupin gets USFDA nod for Oxcarbazepine ER tablets
(
Hot Pursuit
-
09-Jun-25
08:23
)
|
|
|
 |
Other Stories |
 |
|
|
|
|
|
|
|